Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devis Benfaremo

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|February 9, 2018
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel DiseaseMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|May 23, 2020
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|August 9, 2020
Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|May 19, 2025
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT StudyValentino Paci, Fabian Proft, Alice Agostinelli, et al.
Arthritis Research & Therapy|October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyMichele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.
Seminars in Arthritis and Rheumatism|June 11, 2026
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohortValentino Paci, Giulia Marchionni, Alen Zabotti, et al.
RMD Open|February 22, 2023
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria-Grazia Lazzaroni, et al.
Internal and Emergency Medicine|October 16, 2024
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literatureGiulia Bandini, Matteo Monami, Gabriele Ciuti, et al.
Rheumatology (Oxford, England)|October 25, 2023
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patientsMichele Maria Luchetti Gentiloni, Valentino Paci, Ilaria Cimaroli, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|February 9, 2018
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel DiseaseMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|May 23, 2020
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|August 9, 2020
Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|May 19, 2025
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT StudyValentino Paci, Fabian Proft, Alice Agostinelli, et al.
Arthritis Research & Therapy|October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyMichele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.
Seminars in Arthritis and Rheumatism|June 11, 2026
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohortValentino Paci, Giulia Marchionni, Alen Zabotti, et al.
RMD Open|February 22, 2023
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria-Grazia Lazzaroni, et al.
Internal and Emergency Medicine|October 16, 2024
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literatureGiulia Bandini, Matteo Monami, Gabriele Ciuti, et al.
Rheumatology (Oxford, England)|October 25, 2023
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patientsMichele Maria Luchetti Gentiloni, Valentino Paci, Ilaria Cimaroli, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Pageof 7